Skip to main content
. 2016 Jun 27;7(30):48467–48480. doi: 10.18632/oncotarget.10310

Table 1. The main pharmacokinetic parameters of NPPA-PTX and PTX after intravenous administration of the NPPAPTX (equimolar with 5 mg/kg PTX) and Taxol (PTX 5 mg/kg) in rats (mean ± S.D., n = 5).

Parameters Unit PTX NPPA-PTX
Cmax μM 6.2±0.6 6.7±0.8
AUC(0-14) μM*h 6.0±0.5 18.5±1.5**
AUC0-inf μM*h 6.6±0.4 40.1±9.8**
t1/2 h 4.6±1.0 24.4±9.6**
MRT(0-14) h 3.0±0.2 3.9±0.2**
MRT0-inf h 4.9±0.5 28.6±11.4**
**

p<0.01 vs PTX group